(RTTNews) - The Singapore stock market has finished higher in six straight sessions, gathering almost 270 points or 5.3 percent along the way. The Straits Times Index now sits just above the 5,430-point plateau and it's looking at another green light for Friday's trade.
(RTTNews) - The Singapore stock market has finished higher in six straight sessions, gathering almost 270 points or 5.3 percent along the way. The Straits Times Index now sits just above the 5,430-point plateau and it's looking at another green light for Friday's trade.
咨询公司Benchmark Mineral Intelligence (BMI)周五公布的数据显示,6月份全球电动汽车需求连续第四个月增长,主要得益于欧洲市场的强劲增长,而北美市场的销量则有所下滑。纯电动和插电式混合动力汽车6月的注册量同比增长7%,达到200万辆,而上半年注册量同比增长2%。欧洲电动汽车注册量增长31%,达到约53万辆,创下6月纪录新高。BMI表示,欧洲仍是电动汽车增长的主要引擎...
咨询公司Benchmark Mineral Intelligence (BMI)周五公布的数据显示,6月份全球电动汽车需求连续第四个月增长,主要得益于欧洲市场的强劲增长,而北美市场的销量则有所下滑。纯电动和插电式混合动力汽车6月的注册量同比增长7%,达到200万辆,而上半年注册量同比增长2%。欧洲电动汽车注册量增长31%,达到约53万辆,创下6月纪录新高。BMI表示,欧洲仍是电动汽车增长的主要引擎。随着美国电动汽车税收优惠政策结束,北美的注册量下降13%。 责任编辑:王永生
Robert Hershberg, a director at AtaiBeckley Inc. (NASDAQ:ATAI) , sold 100,000 shares of common stock on July 7, 2026, for a total value of $496,000, according to an SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average sale price ($4.96); post-transaction value based on July 7, 2026 market close ($5.19). AtaiBeckley Inc. represents an early-stage biopharmaceutical enterprise w...
Robert Hershberg, a director at AtaiBeckley Inc. (NASDAQ:ATAI) , sold 100,000 shares of common stock on July 7, 2026, for a total value of $496,000, according to an SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average sale price ($4.96); post-transaction value based on July 7, 2026 market close ($5.19). AtaiBeckley Inc. represents an early-stage biopharmaceutical enterprise with a market capitalization of $1.90 billion, currently operating with minimal revenue generation while advancing its clinical development pipeline. The company's strategic focus on innovative mental health therapeutics reflects the growing institutional investment in psychiatric drug development, though its substantial net loss of $663.40 million on TTM basis underscores the capital-intensive nature of clinical-stage biopharmaceutical operations. With 99 employees and operations across three major markets, AtaiBeckley is positioned within the competitive landscape of emerging mental health therapeutics companies seeking to address therapeutic gaps in psychiatric treatment. Continue reading
As infrastructure demands shift toward high-tech facilities and energy transition, choosing between EMCOR Group (NYSE:EME) and Fluor (NYSE:FLR) requires looking at how these engineering giants manage their project backlogs. Both companies provide essential services to industrial and government clients, yet they operate at different scales of project complexity. While one specializes in electrical ...
As infrastructure demands shift toward high-tech facilities and energy transition, choosing between EMCOR Group (NYSE:EME) and Fluor (NYSE:FLR) requires looking at how these engineering giants manage their project backlogs. Both companies provide essential services to industrial and government clients, yet they operate at different scales of project complexity. While one specializes in electrical and mechanical systems for high-tech facilities, the other manages massive global infrastructure projects. Investors often compare them to see which management team handles cyclical swings better. EMCOR Group operates as a specialty construction firm and is frequently grouped among construction stocks due to its focus on mechanical and electrical systems. It serves high-growth areas like data centers, healthcare, and semiconductor manufacturing. Because no single customer represents more than 10% of revenue, the company maintains a highly diversified client base across many industries. Continue reading
On Thursday, an analyst's rather bullish initiation of coverage on Cohu (NASDAQ: COHU) stock clearly resonated with the market. Investors took that pundit's advice to heart, pushing the semiconductor diagnostics company's shares to an almost 6% share price gain that trading session. Just after Wednesday's market close, Baird's Quinn Fredrickson initiated his tracking of Cohu stock by pronouncing i...
On Thursday, an analyst's rather bullish initiation of coverage on Cohu (NASDAQ: COHU) stock clearly resonated with the market. Investors took that pundit's advice to heart, pushing the semiconductor diagnostics company's shares to an almost 6% share price gain that trading session. Just after Wednesday's market close, Baird's Quinn Fredrickson initiated his tracking of Cohu stock by pronouncing it an outperform (i.e., buy). He also set a price target of $65 per share for the highly specialized tech stock, anticipating nearly 18% upside to its current level. Image source: Getty Images. Continue reading